Investors will be anxious to see whether upcoming quarterly reports and outlooks from U.S. companies validate expectations for a strong 2021 rebound in earnings and the economy, which were ravaged by the coronavirus pandemic last year.
U.S. stocks are at record highs, boosted largely by optimism that the rollout of vaccines to fight the COVID-19 virus will allow for that recovery, while hopes of more fiscal stimulus under U.S. President-elect Joe Biden have also underpinned the market.
Earnings reports for the last quarter of 2020 kick off this week, with the release of results from JP Morgan, Citi and other big banks.
Earnings for S&P 500 companies are expected to have dropped 9.8% in the fourth quarter from a year ago, according to IBES data from Refinitiv.
But earnings are expected to rebound this year, with a gain of 16.4% projected for the first quarter. That forecast has improved since the fall, while S&P 500 earnings are expected to grow 23.6% in 2021, benefiting from easy comparisons with 2020.
Investors may be even more keen to find out what company executives say about 2021 than they are to see fourth-quarter results, which come as virus cases are surging across the United States and Europe.
“Managements and analysts are really going to be focused not necessarily on the rear mirror. They’re really thinking about 2021,” said Kenneth Leon, research director at CFRA Research.
What’s also going to be key is “the pulse of each sector and how it affects investors in terms of thinking whether there’s an attractive value there or whether they might need to take a breather,” Leon said.
The S&P 500 is trading at 22.7 times forward earnings, well above the long-term average of about 15, based on Refinitiv’s data.
“Stocks already reflect a pretty positive outlook for earnings,” said Rick Meckler, partner at Cherry Lane Investments, a family investment office in New Vernon, New Jersey.
Earnings for energy and industrials sectors are expected to have declined the most of all sectors in the fourth quarter.
While economically sensitive sectors such as those have been outperforming the broader market in recent months, they still lagged technology for 2020, and their valuations in general are seen by some as less pricey than other sectors.
A large portion of cyclical names fall under the “value” label, and investors have watched the Russell 1000 value index close the gap on the Russell 1000 growth index following upbeat vaccine news.
With virus cases still rising, many strategists expect the bigger recovery to take place in the second half of the year.
“Most likely, second-half outlooks will move higher as corporations gain clarity and ultimately confidence,” Lindsey Bell, chief investment strategist for Ally Invest, wrote in a report Friday.
Yet the uncertainty surrounding the recovery makes getting information from companies even more critical at this stage, even if it’s not “formal” guidance, said Quincy Krosby, chief market strategist at Prudential Financial in Newark, New Jersey.
“That’s important for a market anxious to turn the corner,” after a tough year, she said.
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.